The Biochemical Importance of Arginase in Type 2 Diabetes Pathophysiology: Relationships with Cystatin C, GIP, and GLP-1
Downloads
This is also referred to as adult-onset diabetes mellitus. In this form of diabetes, levels of insulin may be usual, thereby raised, or depressed. This meant the majority of people have insulin resistance and insulin resistance, although insulinopaenia can occur as the illness progresses; or we as a species may define T2DM encompasses primarily resistant to insulin coupled with a relative deficiency of insulin to overwhelmingly a hormonal the secretary deficiencies alongside glucose resistance.
There were 180 participants in two distinct categories of individuals with T2DM were included in this investigation. and controls (140 patients, aged 35 to 65, including 40 apparently healthy controls, 70 uncontrollable DM patients (G1), and 70 managed DM patients (G2). All patients received care at the Kirkuk Teaching the Hospital, El-emel Diyaliz Merkezi, and Azadi Education Hospital in Kirkuk, Iraq, as well as private medical clinics between June 2024 and December 2024. After an overnight fast, venous blood samples were aseptically extracted from the participants via venipuncture. Two sections of the six milliliters were collected. Four milliliters that were kept in a plain tube containing any anticoagulation for 30 minutes at ambient temperatures.
Arginase level and GLP_1 (glocagon-like peptide) and GIP (gastric inhibitory polypeptide) levels have been shown to be negatively correlated in the present investigation and Cystine C Level in patients Diabetic Mellitus compared with Control groups.
1. Henning R J. Type-2 diabetes mellitus and cardiovascular disease. Future cardiology,2018; 14(6): 491-509.
2. McIntyre H D, Catalano P, Zhang C, Desoye G, Mathiesen E R &Damm P. Gestational diabetes mellitus. Nature reviews Disease primers,2019; 5(1): 47.
3. Anggraini, Debie, and Nabila Jihan Zakiyah. "Risk Factors of Type 2 Diabetes Mellitus in the Elderly." Nusantara Hasana Journal 3.10 (2024): 34-40.
4. Satpathy, Siddharth, Lipsa Leena Panigrahi, and Manoranjan Arakha. "The role of selenium nanoparticles in addressing diabetic complications: A comprehensive study." Current Topics in Medicinal Chemistry 24.15 (2024): 1327-1342.
5. D. L. Eizirik, L. Pasquali, and M. Cnop, “Pancreatic beta-cells in type 1 and type 2 diabetes mellitus: different pathways to failure,” Nature Reviews Endocrinology, vol. 16, no. 7, pp. 349–362, 2020.
6. J. Moretto, C. Girard, and C. Demougeot, “The role of arginase in aging: a systematic review,” Experimental Gerontology, vol. 116, pp. 54–73, 2019.
7. Blüher, Matthias, et al. "Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial." Diabetologia 67.3 (2024): 470-482.
8. Huber, Hanna, et al. "Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions–a narrative review." The American journal of clinical nutrition 119.3 (2024): 599-627.
9. Wolfe, M. Michael, Michael O. Boylan, and Wiliam W. Chin. "Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease." Endocrine Reviews (2025): bnaf006.
10. Sumi, Nurunnahar. Association of diet with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) in type-2 diabetic subjects. Diss. © University of Dhaka, 2025.
11. Ciardullo, Stefano, et al. "GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes." Acta Diabetologica 61.8 (2024): 941-950.
12. Souid, Moufida, et al. "Arginase is involved in cervical lesions progression and severity." Immunobiology 227.2 (2022): 152189.
13. Ren, Yuanyuan, et al. "Arginase: biological and therapeutic implications in diabetes mellitus and its complications." Oxidative Medicine and Cellular Longevity 2022.1 (2022): 2419412.
14. Xie, Cong, et al. "Plasma GLP-1 response to oral and intraduodenal nutrients in health and type 2 diabetes—impact on gastric emptying." The Journal of Clinical Endocrinology & Metabolism 107.4 (2022): e1643-e1652.
15. Liu, Yupeng, et al. "The weight-loss effect of GLP-1RAs glucagon-like peptide-1 receptor agonists in non-diabetic individuals with overweight or obesity: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials." The American journal of clinical nutrition 118.3 (2023): 614-626.
16. Alvarez, Isabella, and Daniel Perez. "The Impact of GIP (Gastric Inhibitory Polypeptide) on the Development of Type 2 Diabetes in the Spanish Population: A Longitudinal Study." Sriwijaya Journal of Internal Medicine 2.1 (2024): 25-36.
17. Sapkota, Suman, et al. "Diagnostic accuracy of serum cystatin C for early recognition of nephropathy in type 2 diabetes mellitus." International Journal of Nephrology 2021.1 (2021): 8884126.
18. Zainalaabid, Mustafa Ali, Nihad Najres Hilal, and Amina H. Ahmed. "Evaluation of Myostatin and Some Biochemical Variables in Both Type 2 Diabetic and Diabetic Nephropathy Patients." South Asian Res J Pharm Sci 6.3 (2024): 106-111.
19. Nada Kh. O., Amina H. A. Alobaidi , Firas T. M. Evaluation of fructosamine and glycated albumin in prediabetes in Kirkuk city. Samarra J. Pure Appl. Sci., 2023; 5 (4): 59-65.
20. Salih, Ibrahim Hadi, and Sayran S. Saleh. "Purification of Gamma Glytamyl Transferase and Study Some Biochemical Variables in Sera Patients with Hepatitis B and C in Kirkuk City." Medico-Legal Update 21.2 (2021).
21. Noori N, Murtadha N. Uncontrolled type 2 diabetes mellitus modulated plasma levels of lipid catabolic proteins. Georgian medical news. 2024 lipid catabolic proteins. Georgian medical news. 2024(352-353) :
